Zealand Pharma A/S (CPH:ZEAL)

Market Cap	25.42B -49.7%
Revenue (ttm)	9.21B +14,598.9%
Net Income	6.46B
EPS	90.22
Shares Out	70.61M
PE Ratio	3.99
Forward PE	28.50
Dividend	n/a
Ex-Dividend Date	n/a

Volume	56,960
Average Volume	343,277
Open	360.00
Previous Close	360.00
Day's Range	358.30 - 363.20
52-Week Range	306.10 - 725.00
Beta	0.48
RSI	33.03
Earnings Date	Feb 19, 2026

About Zealand Pharma

Zealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States. The company has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with unmet medical needs. It also provides Zegalogue, a single use syringe or autoinjector for the treatment of severe hypoglycemia; and Dasiglucagon bi-hormone artificial pancreas systems containing insulin and dasiglucagon. Its pipeline includes Dasiglu...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1997
• Employees: 501
• Stock Exchange: Copenhagen Stock Exchange
• Ticker Symbol: ZEAL